Development and evaluation of Panax notoginseng saponins contained in an in situ pH-triggered gelling system for sustained ocular posterior segment drug delivery

Peng Lu, Renxing Wang, Y. Xing, Yanquan Gao, Qingqing Zhang, Bin Xing, Ying Zhang, Chang-hai Yu, Xinfu Cai, Q. Shang, D. Kebebe, Jiaxin Pi, Zhidong Liu
{"title":"Development and evaluation of Panax notoginseng saponins contained in an in situ pH-triggered gelling system for sustained ocular posterior segment drug delivery","authors":"Peng Lu, Renxing Wang, Y. Xing, Yanquan Gao, Qingqing Zhang, Bin Xing, Ying Zhang, Chang-hai Yu, Xinfu Cai, Q. Shang, D. Kebebe, Jiaxin Pi, Zhidong Liu","doi":"10.1097/HM9.0000000000000020","DOIUrl":null,"url":null,"abstract":"Supplemental Digital Content is available in the text Abstract Objective: This study aimed to lay the foundation for the research on Panax notoginseng saponins (PNS) in pH-sensitive in situ gel and the development and improvement of related preparations. Methods: We used Carbopol®940, a commonly used pH-sensitive polymer, and the thickener hydroxypropyl methylcellulose (HPMC E4M) as an ophthalmic gel matrix to prepare an ophthalmic in situ gel of PNS. In addition, formula optimization was performed by assessing gelling capability with the results of in vitro release studies. In vitro (corneal permeation, rheological, and stability) and in vivo (ocular irritation and preliminary pharmacokinetics in the vitreous) studies were also performed. Results: The results demonstrated that the in situ gelling systems containing PNS showed a sustained release of the drug, making it an ideal ocular delivery system for improving posterior ocular bioavailability. Conclusions: This study lays the foundation for the research of PNS contained in an in situ pH-triggered gel as well as the development and improvement of related preparations. It concurrently traditional Chinese medicine with a contemporary in situ gelling approach to provide new directions for the treatment of posterior ocular diseases such as diabetic retinopathy.","PeriodicalId":93856,"journal":{"name":"Acupuncture and herbal medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acupuncture and herbal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/HM9.0000000000000020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Supplemental Digital Content is available in the text Abstract Objective: This study aimed to lay the foundation for the research on Panax notoginseng saponins (PNS) in pH-sensitive in situ gel and the development and improvement of related preparations. Methods: We used Carbopol®940, a commonly used pH-sensitive polymer, and the thickener hydroxypropyl methylcellulose (HPMC E4M) as an ophthalmic gel matrix to prepare an ophthalmic in situ gel of PNS. In addition, formula optimization was performed by assessing gelling capability with the results of in vitro release studies. In vitro (corneal permeation, rheological, and stability) and in vivo (ocular irritation and preliminary pharmacokinetics in the vitreous) studies were also performed. Results: The results demonstrated that the in situ gelling systems containing PNS showed a sustained release of the drug, making it an ideal ocular delivery system for improving posterior ocular bioavailability. Conclusions: This study lays the foundation for the research of PNS contained in an in situ pH-triggered gel as well as the development and improvement of related preparations. It concurrently traditional Chinese medicine with a contemporary in situ gelling approach to provide new directions for the treatment of posterior ocular diseases such as diabetic retinopathy.
用于眼后段持续给药的原位ph触发胶凝系统中三七皂苷的开发与评价
摘要目的:本研究旨在为ph敏感原位凝胶中三七皂苷(PNS)的研究及相关制剂的开发与完善奠定基础。方法:以常用的ph敏感聚合物Carbopol®940和增稠剂羟丙基甲基纤维素(HPMC E4M)为眼用凝胶基质,制备眼用PNS原位凝胶。此外,通过体外释放研究结果评估凝胶性能,对配方进行优化。体外(角膜渗透、流变学和稳定性)和体内(眼刺激和玻璃体中的初步药代动力学)研究也进行了。结果:含PNS的原位胶凝系统具有药物缓释作用,是一种理想的提高眼后生物利用度的眼部给药系统。结论:本研究为原位ph触发凝胶中PNS的研究以及相关制剂的开发和完善奠定了基础。它将中医与当代原位胶凝法相结合,为糖尿病视网膜病变等后眼疾病的治疗提供了新的方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信